{
    "2019-04-29": [
        [
            {
                "time": "",
                "original_text": "同仁堂(600085.SH)一季度净利润升10.18%至3.49亿元",
                "features": {
                    "keywords": [
                        "同仁堂",
                        "一季度",
                        "净利润",
                        "增长",
                        "10.18%",
                        "3.49亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "同仁堂：一季度净利润同比增10.18%",
                "features": {
                    "keywords": [
                        "同仁堂",
                        "一季度",
                        "净利润",
                        "同比增长",
                        "10.18%"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药|行业周报】业绩持续分化，甄选优质赛道和优质个股",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "行业周报",
                        "业绩分化",
                        "优质赛道",
                        "优质个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【华泰医药代雯团队】片仔癀 (600436) 季报点评：高基数下维持快速增长",
                "features": {
                    "keywords": [
                        "华泰医药",
                        "片仔癀",
                        "季报点评",
                        "高基数",
                        "快速增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：机构Q1医药持仓略有下降 荐45股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "机构",
                        "Q1",
                        "医药持仓",
                        "下降",
                        "荐股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：把握医药科创板行情 荐13股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医药",
                        "科创板",
                        "行情",
                        "荐股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【东吴医药】医药周观点20190429:基金医药持仓比例11.3%，较2018年略有提升，建议积极关注有业绩保障的公司",
                "features": {
                    "keywords": [
                        "东吴医药",
                        "周观点",
                        "基金",
                        "医药持仓",
                        "比例",
                        "11.3%",
                        "提升",
                        "业绩保障"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}